Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL671250 | 1.00 | PTPN1 (0.55) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL29865090 | 0.91 | PTPN1 (0.69) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL2036365 | 0.91 | PTPN1 (0.69) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL13280485 | 0.91 | PTPN1 (0.69) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL13280489 | 0.91 | PTPN1 (0.69) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL2036363 | 0.91 | PTPN1 (0.69) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| Hydrochloric Acid SCHEMBL13277952 | 0.89 | PTPN1 (0.67) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| Hydrochloric Acid SCHEMBL13277818 | 0.89 | PTPN1 (0.67) | PTPN1KDM1ALMNAPTGS1PDE4A | |
| SCHEMBL11388752 | 0.87 | KDM1A (0.67) | PTPN1KDM1AMEN1CYP3A4ALOX15 | |
| SCHEMBL11388757 | 0.87 | KDM1A (0.67) | PTPN1KDM1AMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130143247-A1 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2013-06-06 | — | — | US | claimed |
| WO-2012023138-A2 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2012-02-23 | — | — | WO | claimed |
| EP-4677050-A1 | MARINE LUBRICANTS ENABLING FUTURE FUELS | Chevron Oronite Company LLC (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20250042827-A1 | OLEFINS AND METHODS FOR MAKING THE SAME | EUAGORE, LLC | 2025-02-06 | — | — | US | disclosed |
| US-12187674-B2 | Olefins and methods for making the same | Amyris, Inc. (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2024187010-A1 | MARINE LUBRICANTS ENABLING FUTURE FUELS | CHEVRON ORONITE COMPANY LLC (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20240043356-A1 | OLEFINS AND METHODS FOR MAKING THE SAME | EUAGORE, LLC | 2024-02-08 | — | — | US | disclosed |
| US-11802100-B2 | Olefins and methods for making the same | Amyris, Inc. (US) | 2023-10-31 | — | — | US | disclosed |
| WO-2023100932-A1 | GAS SEPARATION MEMBRANE SYSTEM AND GAS SEPARATION MEMBRANE REGENERATION METHOD | UBE株式会社 | 2023-06-08 | — | — | WO | disclosed |
| US-20230167378-A1 | LUBRICATING OIL COMPOSITIONS COMPRISING BIOBASED BASE OILS | CHEVRON ORONITE CO (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20130143247-A1 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2013-06-06 | — | — | US | disclosed |
| US-8309323-B2 | Dimethyloctane as an advanced biofuel | SYNTHETIC GENOMICS, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| WO-2012141783-A1 | OLEFINS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2012141784-A1 | BASE OILS AND METHODS FOR MAKING THE SAME | Amyris, Inc. (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2012023138-A2 | VOLATILE ORGANIC COMPOUNDS FOR DETECTING CELL DYSPLASIA AND GENETIC ALTERATIONS ASSOCIATED WITH LUNG CANCER | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2012-02-23 | — | — | WO | disclosed |
| US-20110160501-A1 | Dimethyloctane as an Advanced Biofuel | SYNTHETIC GENOMICS, INC. | 2011-06-30 | — | — | US | disclosed |
| WO-2009064910-A2 | DIMETHYLOCTANE AS AN ADVANCED BIOFUEL | SYNTHETIC GENOMICS, INC. (US) | 2009-05-22 | — | — | WO | disclosed |
| US-4123465-A | SELECTIVE HYDROGENATION CATALYSTS | HOFFMANN-LA ROCHE INC. (US) | 1978-10-31 | — | — | US | disclosed |
| US-4115417-A | ENANTIOSELECTIVITY | HOFFMANN-LA ROCHE INC. (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160501-A1 | Dimethyloctane as an Advanced Biofuel | MLYCD, DHODH, DGAT2 | PTPN1 4864/4885KDM1A 1145/4885LMNA 4756/4885 |
| US-20250042827-A1 | OLEFINS AND METHODS FOR MAKING THE SAME | HSD17B10, DHCR7, HSD17B12 | PTPN1 4875/4885KDM1A 2929/4885LMNA 2495/4885 |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | PIKFYVE, PIP5K1B, PIP5K1C | PTPN1 335/4885KDM1A 2493/4885LMNA 4275/4885 |
| US-20240043356-A1 | OLEFINS AND METHODS FOR MAKING THE SAME | HSD17B10, DHCR7, HSD17B12 | PTPN1 4875/4885KDM1A 2929/4885LMNA 2495/4885 |
| US-11802100-B2 | Olefins and methods for making the same | HSD17B10, DHCR7, HSD17B12 | PTPN1 4874/4885KDM1A 2783/4885LMNA 2566/4885 |
| US-12187674-B2 | Olefins and methods for making the same | HSD17B10, DHCR7, HSD17B12 | PTPN1 4875/4885KDM1A 2929/4885LMNA 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.